1335210-25-7 Usage
General Description
The chemical compound "(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid" is a complex heterocyclic molecule with a hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine core structure and a carboxylic acid functional group. It has a molecular formula C12H15N3O5 and a molecular weight of 281.264 g/mol. (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid may have potential pharmacological or biological activity, and further research is needed to elucidate its specific properties and potential applications in pharmaceuticals or other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1335210-25-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,5,2,1 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1335210-25:
(9*1)+(8*3)+(7*3)+(6*5)+(5*2)+(4*1)+(3*0)+(2*2)+(1*5)=107
107 % 10 = 7
So 1335210-25-7 is a valid CAS Registry Number.
1335210-25-7Relevant articles and documents
Process for Preparation of Intermediates Used for the Synthesis of HIV Integrase Inhibitor
-
Paragraph 0096-0098, (2021/01/25)
Provided herein is a process for the intermediates used for preparation of HIV Integrase Inhibitor such as Bictegravir, Dolutegravir, Cabotegravir or their pharmaceutically acceptable salts.
An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor
Wang, Huan,Kowalski, Matthew D.,Lakdawala, Ami S.,Vogt, Frederick G.,Wu, Lianming
, p. 564 - 567 (2015/03/04)
A novel synthesis of GSK1265744, a potent HIV integrase inhibitor, is described. The synthesis is highlighted by an efficient construction of the densely functionalized pyridinone core as well as a highly diastereoselective formation of the acyl oxazolidine moiety. The latter exploits the target molecules ability to chelate to Mg2+, a key feature in the integrase inhibitors mechanism of action.